IPOX® VP Kat Liu commented on OpenAI’s accelerated IPO plans in Reuters coverage, noting that the resolution of Elon Musk’s legal challenge “removed a major obstacle” and likely gave the company confidence to speed its timeline. Liu also highlighted the significance of OpenAI potentially filing near SpaceX, saying simultaneous filings could prompt portfolio managers to evaluate both companies side by side. Reuters reported that OpenAI is preparing a confidential U.S. IPO filing in the coming weeks amid major AI interest.

U.S. IPO activity accelerated with major AI, infrastructure, energy and fintech listings, led by SpaceX’s planned $75 billion Nasdaq IPO, Cerebras’ $5.55 billion debut, and Blackstone Digital Infrastructure Trust’s $1.75 billion offering. Forbright, Quantinuum, WhiteHawk and Kraken also advanced IPO plans. In Europe, KNDS pressed ahead with a summer IPO while Germany weighed a stake. In Asia-Pacific, Baidu’s Kunlunxin, Cyan Renewables and KK Mart pursued Hong Kong, Singapore-related and Bursa Malaysia listing options, reflecting renewed global investor appetite for issuance.

IPOX® Associate Lukas Muehlbauer commented in Reuters coverage on Blackstone Digital Infrastructure Trust’s muted market debut after its $1.75 billion IPO. Muehlbauer noted that the timing is crucial because thematic IPO windows can open and close suddenly, adding that strong demand for Cerebras shows the window is currently wide open. He said BXDC could become a template for data center, power or AI infrastructure vehicles, while investors are buying into Blackstone’s execution capability and longstanding sector history.

Reuters reported that EagleRock Land’s NYSE debut delivered a 24.3% gain from its $18.50 IPO price, valuing the Permian-focused landowner at about $3 billion after raising $320.1 million. IPOX® Associate Lukas Muehlbauer was quoted on renewed IPO momentum, noting that demand is strongest for companies tied to artificial intelligence, power demand, energy security and infrastructure. The article highlights continued investor appetite for energy-related listings and broader confidence in new issuance across public markets after several major offerings this week.

Reuters reported that natural gas mineral and royalty business WhiteHawk filed for a U.S. IPO, disclosing a 615% revenue increase in 2025. The article noted renewed investor interest in U.S. energy assets and included commentary from IPOX® Associate Lukas Muehlbauer: “Royalty businesses can be attractive within the sector because they offer exposure to commodity prices and drilling activity without the same spending burden as traditional oil and gas producers.”

Global IPO activity is accelerating across major regions, led by large technology, infrastructure, and consumer listings. In the U.S., Blackstone’s data center vehicle, Cerebras, Quantinuum, Lime, Odyssey, Applied Aerospace & Defense, and Tenneco highlight strong demand for AI, quantum, biotech, mobility, defense, and industrial deals. Europe is seeing London IPO plans from Barnes & Noble/Waterstones and Dangote Cement, while Asia-Pacific features major Hong Kong and Tokyo listings from Syngenta, Kunlunxin, Three-Circle, Go, Sany Heavy, and SkinKandy this year overall globally.

IPOX® CEO Josef Schuster commented on Quantinuum’s U.S. IPO filing in Reuters’ coverage of the Honeywell-backed quantum computing company’s move toward a Nasdaq listing under QNT. Reuters said Quantinuum reported higher revenue and a wider net loss while still in early commercial growth. Schuster said, “Pursing an IPO is always the first best choice to raising money,” even for high-risk quantum deals, citing the open U.S. IPO window and strong investor endorsement of quantum-linked companies overall.

IPOX® CEO Josef Schuster commented on the strength of the U.S. IPO market in Reuters’ coverage of Applied Aerospace & Defense’s IPO filing. Reuters said the defense hardware provider posted a 24.8% revenue increase in 2025, narrowed its net loss, and plans to list on the NYSE under “AADX.” Schuster said, “The U.S. IPO market is in its best shape I have seen it since the late 1990s,” adding the recovery reflects “strong post-IPO returns” and broad deal reception.

Reuters reported that Odyssey Therapeutics reached a nearly $900 million valuation after shares rose in its Nasdaq debut. IPOX® Research Associate Lukas Muehlbauer said the trend suggests the “biotech IPO window is open again after a lackluster 2025.” He also noted, “In a biotech market where M&A remains an important exit route for recently listed companies, investors may view Glick’s history as adding to Odyssey’s appeal,” citing founder Dr. Gary D. Glick’s biotech track record.

Reuters reports Lime filed for a U.S. IPO, with IPOX® Research Associate Lukas Muehlbauer noting, “Lime’s filing reflects both a better IPO market and a stronger company profile than in the previous years.” He added, “While the underlying picture has improved meaningfully, the main caveat is that the company remains loss-making and investors will look closely at whether they can turn strong revenue numbers into more consistent profitability.” Lime plans to list on Nasdaq under “LIME.”

Reuters reports Blackstone Digital Infrastructure Trust is aiming to raise slightly over $1.7 billion in a U.S. IPO to acquire newly built data centers amid strong demand for AI-linked infrastructure. IPOX® CEO Josef Schuster is quoted on the strength of the U.S. IPO market, noting that gains in AI- and energy-related deal flow have supported sentiment and demand for new listings. The Blackstone vehicle plans to list on the NYSE under the symbol “BXDC.”

Reuters reports Cerebras Systems is targeting a valuation of up to $26.62 billion in its U.S. IPO, amid strong investor demand for AI infrastructure and advanced chips. IPOX® Research Associate Lukas Muehlbauer is quoted on Cerebras’ competitive positioning against Nvidia, its role as a signal deal for high-growth AI infrastructure listings, and the potential race to complete offerings before a major SpaceX IPO draws investor attention and capital in the Reuters article published May 4, 2026.

Global IPO activity remains active across major regions, led by large U.S. listing plans from SpaceX, Roze AI, SK Hynix, Tenneco and Pershing Square USA. Europe’s pipeline includes delayed or potential listings from RAC, Dolomiti Energia and BioMar, while Singapore is advancing dual U.S.-Singapore listing rules. In MENA, Saudi Arabia’s DABS IPO is testing investor confidence amid volatility, highlighting selective resilience despite a sharp regional slowdown in issuance across the wider GCC market.

Reuters reported that Bill Ackman’s Pershing Square and Pershing Square USA are set to list on the NYSE after Pershing Square USA raised $5 billion in its IPO. The debut marks Ackman’s renewed effort to bring a flagship U.S.-listed fund to market and tests investor appetite for closed-end funds. IPOX® Research Associate Lukas Muehlbauer was quoted on the offering’s structure, noting that shares of the managing company may have helped support investor demand beyond the fund alone in the listing.

Reuters reported that Rare Earths Americas launched its U.S. IPO roadshow, targeting a valuation of up to $368.4 million amid rising investor interest in critical minerals. The company plans to raise up to $52.8 million and list on NYSE American under “REA”. IPOX® Associate Lukas Muehlbauer was quoted, noting the company’s role in supply-chain diversification and the potential M&A appeal of newly public rare earth companies in a strategically important sector as global demand continues to accelerate sharply worldwide.